Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)
CNY 13.74
(1.63%)
CNY 13.74
(1.63%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 10.31 Billion CNY | -18.75% |
| 2022 | 12.53 Billion CNY | 23.88% |
| 2021 | 10.11 Billion CNY | 15.19% |
| 2020 | 8.78 Billion CNY | 50.76% |
| 2019 | 5.82 Billion CNY | 20.99% |
| 2018 | 4.81 Billion CNY | 17.97% |
| 2017 | 4.08 Billion CNY | 6.84% |
| 2016 | 3.82 Billion CNY | 19.95% |
| 2015 | 3.18 Billion CNY | 9.02% |
| 2014 | 2.92 Billion CNY | 17.31% |
| 2013 | 2.49 Billion CNY | 51.04% |
| 2012 | 1.64 Billion CNY | -15.59% |
| 2011 | 1.95 Billion CNY | 18.43% |
| 2010 | 1.64 Billion CNY | 1.04% |
| 2009 | 1.63 Billion CNY | 73.92% |
| 2008 | 938.55 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 1.74 Billion CNY | -15.28% |
| 2024 Q1 | 2.47 Billion CNY | 44.19% |
| 2024 Q2 | 2.05 Billion CNY | -17.11% |
| 2023 Q3 | 1.78 Billion CNY | -37.52% |
| 2023 Q4 | 1.71 Billion CNY | -3.67% |
| 2023 Q1 | 3.93 Billion CNY | -14.21% |
| 2023 Q2 | 2.85 Billion CNY | -27.43% |
| 2023 FY | 10.18 Billion CNY | -18.75% |
| 2022 Q3 | 2.37 Billion CNY | -16.34% |
| 2022 Q2 | 2.84 Billion CNY | 4.5% |
| 2022 Q1 | 2.72 Billion CNY | 35.74% |
| 2022 Q4 | 4.58 Billion CNY | 92.76% |
| 2022 FY | 12.53 Billion CNY | 23.88% |
| 2021 FY | 10.11 Billion CNY | 15.19% |
| 2021 Q1 | 3.66 Billion CNY | 57.1% |
| 2021 Q2 | 2.22 Billion CNY | -39.27% |
| 2021 Q3 | 2.21 Billion CNY | -0.55% |
| 2021 Q4 | 2 Billion CNY | -9.49% |
| 2020 Q3 | 1.96 Billion CNY | -8.95% |
| 2020 Q4 | 2.33 Billion CNY | 19.11% |
| 2020 FY | 8.78 Billion CNY | 50.76% |
| 2020 Q1 | 2.33 Billion CNY | 57.88% |
| 2020 Q2 | 2.15 Billion CNY | -7.73% |
| 2019 Q3 | 1.36 Billion CNY | -4.97% |
| 2019 Q1 | 1.54 Billion CNY | 56.81% |
| 2019 Q2 | 1.43 Billion CNY | -7.46% |
| 2019 Q4 | 1.47 Billion CNY | 8.45% |
| 2019 FY | 5.82 Billion CNY | 20.99% |
| 2018 Q3 | 1.12 Billion CNY | 0.55% |
| 2018 FY | 4.81 Billion CNY | 17.97% |
| 2018 Q1 | 1.58 Billion CNY | 54.72% |
| 2018 Q2 | 1.11 Billion CNY | -29.16% |
| 2018 Q4 | 988.4 Million CNY | -12.21% |
| 2017 Q1 | 1.31 Billion CNY | 41.36% |
| 2017 Q3 | 814.83 Million CNY | -12.4% |
| 2017 FY | 4.08 Billion CNY | 6.84% |
| 2017 Q4 | 1.02 Billion CNY | 25.37% |
| 2017 Q2 | 930.19 Million CNY | -29.25% |
| 2016 FY | 3.82 Billion CNY | 19.95% |
| 2016 Q1 | 1.1 Billion CNY | 51.39% |
| 2016 Q2 | 928.82 Million CNY | -15.7% |
| 2016 Q3 | 859.54 Million CNY | -7.46% |
| 2016 Q4 | 930.03 Million CNY | 8.2% |
| 2015 Q1 | 859.49 Million CNY | 22.13% |
| 2015 Q4 | 727.73 Million CNY | -3.17% |
| 2015 Q3 | 751.56 Million CNY | -11.16% |
| 2015 Q2 | 845.95 Million CNY | -1.58% |
| 2015 FY | 3.18 Billion CNY | 9.02% |
| 2014 Q4 | 703.74 Million CNY | 3.46% |
| 2014 FY | 2.92 Billion CNY | 17.31% |
| 2014 Q2 | 736.19 Million CNY | -8.09% |
| 2014 Q1 | 801.03 Million CNY | 21.43% |
| 2014 Q3 | 680.18 Million CNY | -7.61% |
| 2013 Q4 | 659.68 Million CNY | -2.16% |
| 2013 FY | 2.49 Billion CNY | 51.04% |
| 2013 Q1 | 580.43 Million CNY | -0.87% |
| 2013 Q2 | 575.8 Million CNY | -0.8% |
| 2013 Q3 | 674.23 Million CNY | 17.09% |
| 2012 FY | 1.64 Billion CNY | -15.59% |
| 2012 Q1 | 440.13 Million CNY | -21.84% |
| 2012 Q2 | 262.63 Million CNY | -40.33% |
| 2012 Q3 | 360.34 Million CNY | 37.2% |
| 2012 Q4 | 585.55 Million CNY | 62.5% |
| 2011 Q1 | 420.14 Million CNY | -28.62% |
| 2011 Q2 | 468.94 Million CNY | 11.61% |
| 2011 Q3 | 500.96 Million CNY | 6.83% |
| 2011 Q4 | 563.16 Million CNY | 12.42% |
| 2011 FY | 1.95 Billion CNY | 18.43% |
| 2010 Q3 | 397.34 Million CNY | 0.0% |
| 2010 Q4 | 588.6 Million CNY | 48.13% |
| 2010 FY | 1.64 Billion CNY | 1.04% |
| 2009 FY | 1.63 Billion CNY | 73.92% |
| 2008 FY | 938.55 Million CNY | 0.0% |